Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 26 (ZBTB26) is a nuclear transcription factor that contains zinc finger motifs and a BTB domain, which enable sequence-specific double-stranded DNA binding and protein-protein interactions. The protein is predicted to be involved in the negative regulation of gene transcription mediated by RNA polymerase II, cytokine production, and regulation of immune system processes. It is primarily localized in the nucleus and nucleoplasm. ZBTB26 is a protein coding gene, with roles implicated in transcriptional regulation. A disease association is reported for congenital hypothyroidism, although its broader implications in disease are not well characterized. No drugs are currently known to interact with ZBTB26, and there are no established biomarkers or specific safety concerns related to this target. If further information on structure, interactions, or pathway context is needed, this protein's metabolic and physical interaction networks can be explored in resources like the Human Protein Atlas and UniProt.
Not applicable (no drugs targeting ZBTB26 are known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 26 (ZBTB26).